[1] 中华医学会血液学分会止血与血栓学组. 成人原发免疫性血小板减少症诊断与治疗中国专家共识(2016年版)[J].中华血液学杂志,2016,37(2):89-93.
[2] Qiu J, Liu X, Li X, et al.CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia[J]. Sci Rep,2016,6:27445.
[3] 侯明. 原发免疫性血小板减少症的现状与展望[J]. 中华血液学杂志,2012,33(9):697-698.
[4] Dasgupta A, Saxena R.Regulatory T cells: a review[J]. Natl Med J India,2012,25(6):341-351.
[5] Hu Y, Wang X, Yu S, et al.Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imba-lance via T-helper 17-associated signaling pathway in immune thrombocytopenia[J]. Expert Opin Ther Targets,2015,19(6):723-732.
[6] Zufferey A, Kapur R, Semple JW.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)[J]. J Clin Med,2017,6(2):E16.
[7] Lewkowicz N, Klink M, Mycko MP, et al.Neutrophil--CD4+CD25+ T regulatory cell interactions: a possible new mechanism of infectious tolerance[J]. Immunobiology,2013, 218(4):455-464.
[8] Ulivieri C, Baldari CT.T-cell-based immunotherapy of autoimmune diseases[J]. Expert Rev Vaccines,2013,12(3):297-310.
[9] Sakaguchi S, Sakaguchi N, Asano M, et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol,1995,155(3):1151-1164.
[10] Rangachari M, Kuchroo VK.Using EAE to better understand principles of immune function and autoimmune pathology[J]. J Autoimmun,2013,45:31-39.
[11] Zhu M, Mo H, Li D, et al.Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus(SLE)[J]. Clin Rheumatol,2013,32(7):1045-1052.
[12] He X, Landman S, Bauland SC, et al.A TNFR2-agonist facilitates high purity expansion of human low purity treg cells[J]. PLoS One,2016,11(5):e0156311.
[13] Talaat RM, Elmaghraby AM, Barakat SS, et al.Altera-tions in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)[J]. Clin Exp Immunol,2014,176(2):291-300.
[14] Wang H, Li L, Zhang Y, et al.Expression and significance of CD4(+)CD25(+)CD127(-) regulatory T cells in peripheral blood of patients with different phenotypes of Guillain-Barré syndrome[J]. Int J Clin Exp Med,2015,8(10):19126-19131.
[15] Henríquez C, Morán G, Carrasco C, et al.Modulatory role of regulatory T cells in a murine model of severe equine asthma[J]. BMC Vet Res,2017,13(1):117.
[16] Son BR, Kim JY.Association of CD4(+)CD25(+)FoxP3(+) regulatory T cells with natural course of childhood chro-nic immune thrombocytopenic purpura[J]. Korean J Pe-diatr,2015,58(5):178-182.
[17] Wang J, Yang J.Identification of CD4+CD25+CD127- regulatory T cells and CD14+HLA-DR-/low myeloid-derived suppressor cells and their roles in the prognosis of breast cancer[J]. Biomed Rep,2016,5(2):208-212.
[18] Liu W, Putnam AL, Xu-Yu Z, et al.CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells[J]. J Exp Med,2006,203(7):1701-1711.
[19] Miyara M, Sakaguchi S.Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns[J]. Immunol Cell Biol,2011,89(3):346-351.
[20] 刘红云, 马丽萍, 魏菁, 等. 小鼠调节性T细胞的CD4+CD25+CD127low/-标记分析[J]. 中国实验血液学杂志,2012,20(6):1469-1473.
[21] 黄文烨, 孙秋惠, 陈冶平. CD4+CD25+CD127low调节性T细胞、TGF-β及Notch1基因在特发性血小板减少性紫癜发病机制中作用研究[J]. 中国实验血液学杂志,2015,23(6):1652-1656.
[22] Nishimoto T, Kuwana M.CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia[J]. Semin Hematol,2013,50(Suppl 1):S43-S49.
[23] Aslam R, Hu Y, Gebremeskel S, et al.Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia[J]. Blood,2012,120(10):2127-2132.
[24] Li Z, Mou W, Lu G, et al.Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell leve-ls in patients with immune thrombocytopenia[J]. Int J Hematol,2011,93(1):91-98.
[25] 郭新红, 范佳鑫, 阿依姆妮萨·阿卜杜热合曼, 等. CD4+CD25+CD127low调节性T细胞及相关细胞因子与慢性特发性血小板减少性紫癜的研究[J]. 中国免疫学杂志,2011,27(1):73-75.
[26] Mazzucco KL, Junior LM, Lemos NE, et al.Assessment of regulatory T cells in childhood immune thrombocytopenic purpura[J]. ISRN Hematol,2013,2013:143687.
[27] Akyol Erikçi A, Karagöz B, Bilgi O.Regulatory T cells in patients with idiopathic thrombocytopenic purpura[J]. Turk J Haematol,2016,33(2):153-155.
[28] Raphael I, Nalawade S, Eagar TN, et al.T cell subsets and their signature cytokines in autoimmune and inflammatory diseases[J]. Cytokine,2015,74(1):5-17.
[29] Ueno H, Banchereau J, Vinuesa CG.Pathophysiology of T follicular helper cells in humans and mice[J]. Nat Immunol,2015,16(2):142-152.
[30] Jiang H, Wu X, Zhu H, et al.FOXP3(+)Treg/Th17 cell imbalance in lung tissues of mice with asthma[J]. Int J Clin Exp Med,2015,8(3):4158-4163.
[31] Jadidi-Niaragh F, Mirshafiey A.Th17 cell, the new player of neuroinflammatory process in multiple sclerosis[J]. Scand J Immunol,2011,74(1):1-13.
[32] Lee SY, Lee SH, Yang EJ, et al.Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17/Treg balance[J]. PLoS One,2015,10(9):e0135858.
[33] Ji L, Zhan Y, Hua F, et al.The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia[J]. PLoS One,2012,7(12):e50909.
[34] Rocha AM, Souza C, Rocha GA, et al.The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia[J]. Haematologica,2011,96(10):1560-1564.
[35] Wang JD, Chang TK, Lin HK, et al.Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia(ITP)[J]. Pediatr Blood Cancer,2011,57(4):636-640.
[36] 王潇, 周郁鸿, 陈小红, 等. Th17细胞在特发性血小板减少性紫癜发病中的作用和意义[J]. 中国实验血液学杂志,2016,24(6):1833-1836.
[37] Hu Y, Wang X, Yu S, et al.Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imba-lance via T-helper 17-associated signaling pathway in immune thrombocytopenia[J]. Expert Opin Ther Targets,2015,19(6):723-732.
[38] Sun T, Zhang D, Yang Y, et al.Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia[J]. Br J Haematol,2015,169(2):278-285.
[39] 韩晓凤, 倪蓓文, 方怡, 等. 妊娠合并原发免疫性血小板减少症患者的临床特点分析及T细胞分泌细胞因子水平的研究[J]. 诊断学理论与实践,2016,2016(2):152-156.
